BEIJING, April 29, 2022 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a healthcare provider specializing in the treatment, research, education and prevention of cancer in establishing proton centers, high-end cancer hospitals and specialty cancer hospitals and operating an extensive network of radiation therapy and diagnostic imaging centers in Chinatoday announced that it has filed its annual report on Form 20-F for the year ended December 31, 2021 (the “Annual Report”) with the United States Securities and Exchange Commission. An electronic copy of the annual report may be viewed on Concord Medical’s Investor Relations website at http://ir.ccm.cn and on the SEC’s website at www.sec. gov. Shareholders can receive a paper copy of the annual report free of charge upon request. Applications should be submitted to http://ir.ccm.cn.
About Concord Medical
Concord Medical Services Holdings Limited (NYSE: CCM) is a full-cycle healthcare provider of premium oncology services, including cancer diagnosis, treatment, education and prevention. The Company is focused on providing a multidisciplinary approach to cancer care in all areas of oncology services in its cancer hospitals and equipping its hospitals with technologically advanced equipment such as proton therapy system peak. Together with leading national and international intelligence services, we strive to improve the quality and accessibility of cancer care. Our network of medically advanced cancer hospitals and clinics and partner hospitals across China ensures commitment to the highest level of medical services for patients. Because, being the most trusted cancer partner for patients is our vision. For more information, please see http://ir.ccm.cn.
View original content: https://www.prnewswire.com/news-releases/concord-medical-files-2021-annual-report-on-form-20-f-301536673.html
SOURCE Concord Medical Services Holdings Limited